Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer
Liam J. Brockley, Vanessa G. P. Souza, Aisling Forder, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2275-2275
Open Access | Times Cited: 11

Showing 11 citing articles:

Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis
Vanessa G. P. Souza, Aisling Forder, Liam J. Brockley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8894-8894
Open Access | Times Cited: 16
Can long-read sequencing tackle the barriers, which the next-generation could not? A review
Nikolett Szakállas, Barbara Kinga Barták, Gábor Valcz, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 1
Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers
Jun Ho Chung, Sophie Xiao, Yang Gao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8703-8703
Open Access | Times Cited: 1
Clinical bioinformatics desiderata for molecular tumor boards
Matteo Pallocca, Martina Betti, Sara Baldinelli, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges
Débora Dummer Meira, Maria Clara de Castro e Caetano, Matheus Correia Casotti, et al.
Genes (2023) Vol. 14, Iss. 10, pp. 1906-1906
Open Access | Times Cited: 4
The future of precision medicine in oncology
Ahmad Z. Al Meslamani
Expert Review of Precision Medicine and Drug Development (2023) Vol. 8, Iss. 1, pp. 43-47
Open Access | Times Cited: 4
Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic Nonsmall-cell Lung Cancer
Anne Shah, Jon Apple, Saad Aslam, et al.
American Journal of Clinical Oncology (2024)
Open Access
Precision medicine for patients with salivary gland neoplasms: Determining the feasibility of implementing a next-generation sequencing-based RNA assay in a hospital laboratory
Gloria H. Sura, Jim Hsu, Dina R. Mody, et al.
CytoJournal (2024) Vol. 21, pp. 48-48
Open Access
HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma
Yue Li, Yu Wang, Ruhao Wu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
From photonic technologies to microfluidics—A review on the techniques which revolutionize liquid biopsy, opening a new era in cancer therapy
Subham Sarkar, Soubhagya Ghosh, Samraggi Chakraborty, et al.
Health Science Reports (2024) Vol. 7, Iss. 11
Open Access
Deep Learning-Based Analysis of Liquid Biopsies for Uterus Cancer Biomarker Discovery
S. D. Lalitha, Mohammed Irfanul Haque, V. Sujay, et al.
2022 8th International Conference on Smart Structures and Systems (ICSSS) (2023), pp. 1-6
Closed Access
Page 1

Scroll to top